Microport Cardioflow Medtech

Microport Cardioflow Medtech Current Assets

The Current Assets of Microport Cardioflow Medtech (2160.HK) as of Nov 16, 2026 is 1.67 B CNY. In the previous year, Current Assets was 2.04 B CNY — a change of -17.97% (lower).

Current Assets

1.67 BCNY

YoY

-17.97%

Last updated:

Current Assets of Microport Cardioflow Medtech is 2024 1.67 B CNY. Current Assets of Microport Cardioflow Medtech was 2023 2.04 B CNY. It decreases by -17.97% lower compared to the previous year.

The Microport Cardioflow Medtech Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
77.35 M CNY
Jan 1, 2019
183.73 M CNY
Jan 1, 2020
719.97 M CNY
Jan 1, 2021
2.60 B CNY
Jan 1, 2022
2.27 B CNY
Jan 1, 2023
2.04 B CNY
Jan 1, 2024
1.67 B CNY
The Microport Cardioflow Medtech Current Assets history
YEARCurrent AssetsYoY
1.67 BCNY-17.97%
2.04 BCNY-10.14%
2.27 BCNY-12.62%
2.60 BCNY+261.10%
719.97 MCNY+291.86%
183.73 MCNY+137.54%
77.35 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microport Cardioflow Medtech Stock analysis

What does Microport Cardioflow Medtech do? MicroPort CardioFlow Medtech Corp. develops and commercializes transcatheter and surgical solutions for valvular heart diseases, primarily focusing on the domestic market. The company's main products are the first-generation TAVI product VitaFlow and the second-generation TAVI product VitaFlow II, which are used for transcatheter aortic heart valve implantation. These products are sold to healthcare providers and hospitals within China, where the company operates under its holding company structure. The firm generates revenue through the sale of its medical devices, specifically the VitaFlow and VitaFlow II systems, targeting hospitals and medical institutions that require advanced cardiac solutions. As a domestic-focused entity, MicroPort CardioFlow's business model relies on the commercialization of its TAVI products within China's healthcare sector, with no mention of international markets or additional product lines beyond the two TAVI systems. Microport Cardioflow Medtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Microport Cardioflow Medtech stock

Current Assets of Microport Cardioflow Medtech is 1.67 B CNY in 2024.

Current Assets of Microport Cardioflow Medtech changed from 2.04 B CNY to 1.67 B CNY, representing a -17.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Microport Cardioflow Medtech since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Microport Cardioflow Medtech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Microport Cardioflow Medtech

All Key Metrics — Microport Cardioflow Medtech